T1	Participants 108 140	population-based screening study
T2	Participants 457 586	randomized population-based screening study (Rotterdam section of the European Randomized Study of Screening for Prostate Cancer)
T3	Participants 597 607	10,865 men
T4	Participants 632 693	biopsy results of 1202 men with PSA levels of 4 ng/mL or more
T5	Participants 878 981	57 radical prostatectomy specimens through Spearman's rank correlation coefficient and agreement tests.
